- Treatments & Services
FibroScan® Liver Health Assessment
- Request an appointment
On this page
Early Detection, Intelligent Intervention, and Reversible Outcomes
A Silent and Growing Epidemic
Fatty liver disease — including what’s now often referred to as metabolic dysfunction-associated steatotic liver disease (MASLD) — affects as many as 25–38% of adults in the United States and around the world. Many individuals are completely unaware they have it
That means roughly one in three adults has excess fat in their liver, often without symptoms or abnormal routine labs.
This is not rare. This is not normal aging. It is a metabolic health crisis playing out inside millions of bodies.
Why Early Detection Matters
Fatty liver isn’t a static condition. It is a spectrum, beginning with simple fat accumulation and potentially progressing to:
- Metabolic dysfunction-associated steatohepatitis (MASH) — liver inflammation
- Fibrosis — early scar formation
- Cirrhosis — advanced scarring, decreased liver function
- Complications — including liver failure and increased cancer risk
Between 10% and 30% of people with fatty liver develop MASH, which significantly increases the risk of progression to cirrhosis if untreated
One long-term study showed that over about eight years, up to 39% of patients progressed from NAFLD to cirrhosis and nearly half of those with early cirrhosis advanced further.
These are not distant risks — they are real outcomes that grow more likely with time and metabolic stress.
What FibroScan® Actually Measures
FibroScan® uses transient elastography — a specialized ultrasound impulse — to provide objective, clinician-interpretable data on:
- Liver fat content (steatosis)
- Liver stiffness (fibrosis)
Without needles.
Without sedation.
Done in minutes.
This gives us insight far beyond routine liver enzyme tests, which often remain normal even when significant disease is present.
Why Traditional Care Fails Too Often
In typical practice:
- Fatty liver may be mentioned, but not quantified
- Severity is often not staged
- No structured follow-up plan is developed
- Patients are told to “lose weight” without a measurable strategy
As a result, disease can silently progress for years — and when symptoms finally surface, complications are already advanced.
At James Clinic, we believe in measurable medicine.
The James Clinic Approach
Evaluate → Treat → Reassess
We use FibroScan® to establish a baseline, defining not just the presence of fat, but how much and whether fibrosis is emerging.
Your plan isn’t generic. It is personalized and based on underlying metabolic drivers, including:
- Insulin resistance and glycemic control
- Lipid metabolism and weight distribution
- Inflammation and oxidative stress
- Hormone balance
- Nutrition and mitochondrial support
- Targeted lifestyle and adjunctive therapies
These interventions are chosen based on data, not guesswork.
FibroScan® is repeatable. We track improvement or progression over time and adjust the plan accordingly.
This is the opposite of passive monitoring — it’s proactive health management.
Your Liver Predicts Much More Than Liver Disease
Fatty liver is a marker of systemic metabolic dysfunction. Addressing it has implications for:
- Cardiovascular health
- Type 2 diabetes prevention and management
- Cognitive resilience
- Hormonal balance
- Longevity outcomes
This isn’t liver care in a vacuum.
It’s whole-body metabolic optimization.
Who Should Consider FibroScan® Testing
This assessment is especially valuable for people who:
- Have elevated liver enzymes
- Have metabolic syndrome or insulin resistance
- Carry excess visceral fat
- Have prediabetes or type 2 diabetes
- Are focused on preventative longevity care
- Want objective, actionable tracking of liver health
You do not need symptoms to benefit — fatty liver is often silent until it’s late.
What the Test Is Like
FibroScan® is:
- Non-invasive
- Comfortable
- Performed in-office
- Completed in minutes
- No needles, no anesthesia, no downtime
You’ll lie comfortably while the device evaluates liver stiffness and fat content through painless ultrasound impulses.
The James Clinic Difference
Most physicians stop after delivering a diagnosis.
We go further:
- We quantify disease severity
- We identify drivers of dysfunction
- We design personalized, evidence-aligned plans
- We use repeat testing to document improvement
Fatty liver is not something we “watch.”
It’s something we manage, improve, and reverse when possible.
FibroScan® & Fatty Liver Disease
Frequently asked questions
Fatty liver disease occurs when excess fat accumulates in liver cells. Today it is most commonly driven by metabolic dysfunction, insulin resistance, inflammation, and hormonal imbalance rather than alcohol.
It is now often referred to as MASLD (Metabolic Dysfunction–Associated Steatotic Liver Disease) and affects an estimated 25–38% of adults.
Fatty liver is not benign. It is an early warning sign of systemic metabolic stress.
Yes. While early fatty liver may be reversible, it exists on a spectrum of disease.
Without intervention, fatty liver can progress to:
- Liver inflammation (MASH)
- Fibrosis (scarring)
- Cirrhosis
- Liver failure or increased cancer risk
Progression often occurs silently, without symptoms or abnormal routine labs.
In many cases, yes.
Fatty liver is one of the most reversible metabolic conditions when addressed early and correctly. Reversal depends on:
- Improving insulin sensitivity
- Reducing inflammation
- Optimizing metabolism and hormones
- Addressing lifestyle and nutritional drivers
This is why James Clinic focuses on early detection and active treatment, not passive monitoring.
In traditional care, fatty liver is often:
- Mentioned incidentally on imaging
- Not staged or graded
- Not followed longitudinally
- Addressed only with vague lifestyle advice
Without objective measurement or follow-up, it’s easy for fatty liver to be minimized. At James Clinic, we treat it as a measurable and actionable condition, not a footnote.
Routine liver enzymes (AST, ALT) often remain normal even when fatty liver or fibrosis is present.
FibroScan®:
- Measures liver fat and stiffness directly
- Detects disease earlier
- Grades severity objectively
- Allows tracking of improvement or progression
It fills a major blind spot in conventional screening.
In most cases, no.
FibroScan® provides reliable, non-invasive assessment of liver fat and fibrosis without:
- Needles
- Sedation
- Recovery time
Biopsies are now reserved for select, advanced cases or unclear diagnoses.
The most common drivers include:
- Insulin resistance
- Metabolic syndrome
- Excess visceral fat
- High sugar or ultra-processed diets
- Hormonal imbalance
- Chronic inflammation
- Sedentary lifestyle
Alcohol is only one possible contributor and is not required for fatty liver to develop.
This depends on your baseline findings and treatment plan.
At James Clinic, FibroScan® is typically repeated:
- After a defined treatment interval
- To document improvement
- To reassess risk and adjust strategy
If you’re not measuring change, you’re guessing.
Yes. Improving liver health often leads to:
- Better cholesterol and triglyceride levels
- Improved blood sugar control
- Reduced cardiovascular risk
- Better energy and cognition
- Improved hormone metabolism
The liver is central to whole-body health.
Strongly.
Fatty liver is independently associated with:
- Increased cardiovascular disease risk
- Higher all-cause mortality
- Metabolic syndrome progression
In many cases, fatty liver is an early cardiovascular warning sign, not just a liver issue.
Without intervention, fatty liver may:
- Progress quietly for years
- Lead to fibrosis and cirrhosis
- Increase risk of diabetes and heart disease
- Become irreversible at later stages
Early action dramatically changes the trajectory.
We don’t stop at diagnosis.
At James Clinic, we:
- Quantify severity with FibroScan®
- Identify metabolic and hormonal drivers
- Build individualized, cost-effective treatment plans
- Reassess objectively to confirm improvement
This is active management, not watchful waiting.
FibroScan® is especially valuable if you:
- Have elevated liver enzymes
- Have insulin resistance, prediabetes, or diabetes
- Carry excess abdominal fat
- Have abnormal cholesterol or triglycerides
- Want proactive longevity care
- Want to measure and track liver health objectively
You do not need symptoms to benefit.
Fatty liver is common.
Progression is not inevitable.
Reversal is possible.
But only if it’s measured, addressed, and reassessed.
FibroScan® liver assessment at James Clinic provides clarity and a path forward.
Early detection changes the story.
Action changes the outcome.